CRISPR-based knock-in correction of the H3.3G34R mutation in paediatric glioblastoma (pGBM) cells significantly reduces RACK7 chromatin binding and inhibits the same gene set as RACK7 knockout in H3.3G34R pGBM cells [85]. Here, ZMYND8 is linked to glioblastoma.